- Home Page
- Sales & Partners
- News & Events
- Site Map
|Method & Line||Sample & Target||Product||Package Info||Product||Package Info|
|Clinical Chemistry||Plasma,Serum||LDH-P||Tests per Package: 953|
|Pchem Reagents||The Pchem LDH-P Reagent Kit has been designed for use in the quantitative determination in vitro of the LDH activity in human serum or plasma. The results of the test must always be interpreted in conjunction with the clinical picture.||Code: ADA-R0200001201||Package: R1 4 x 45.0 mL; R2 4 x 5.5 mL|
Please pay attention to the revision of the document that must be the same as the revision reported in the box label.
In case of discrepancy please contact our Customer Care e-mail: firstname.lastname@example.org.
* Other document related to the product available at Documentation Centre and it is accessible for Adaltis distributors/partners after registration only.
The Pchem LDH-P Reagent Kit has been designed for use in the quantitative determination in vitro of the LDH activity in human serum or plasma. The results of the test must always be interpreted in conjunction with the clinical picture.
This kit is intended for In vitro diagnostic use only, must not be sold to the general public and the test has to be carried out by a health-care professional person.
The kit contains reagents sufficient for 953 tests.
LDH is an enzyme which catalyzes the reduction of pyruvic acid to lactic acid. The wide-spread diffusion of LDH in the organism explains why this enzyme increases in the serum in numerous pathological conditions involving various different tissues, such as the liver (viral hepatitis), cardiac muscle(myocardial infarction), skeletal muscle and kidneys. The kidney is the organ containing the highest concentration of the enzyme, followed by the myocardium, skeletal muscle, spleen, liver and lungs. LDH activity in the serum is determined by a group of five isoenzymes deriving from different tissues. LDH activity can be determined by measuring the conversion of lactate to pyruvate or pyruvate to lactate. Hill and Levi in 1954, Wròblewski and La Duein 1956, and Blachaer in 1961 developed methods based on the use of NADH. The Adaltis S.r.l. method has been optimized according to the suggestions proposed by the Scandinavian Society for Clinical Chemistry (1).
Pchem LDH-P Reagent Kit
Reagent 1 (R1) - 4 x 45 mL/vial
Reagent 2 (R2) - 4 x 5.5 mL/vial